Abstract
This position statement is based on the current evidence available on the safety and benefits of continuous subcutaneous insulin pump therapy (CSII) in diabetes with an emphasis on the effects of CSII on glycemic control, hypoglycaemia rates, occurrence of ketoacidosis, quality of life and the use of insulin pump therapy in pregnancy. The current article represents the recommendations of the Austrian Diabetes Association for the clinical praxis of insulin pump treatment in children, adolescents and adults.
Keywords:
Diabetes mellitus; Guidelines; Insulin pump therapy.
MeSH terms
-
Adolescent
-
Adult
-
Austria
-
Child
-
Child, Preschool
-
Diabetes Mellitus / diagnosis*
-
Diabetes Mellitus / drug therapy*
-
Diabetes Mellitus / psychology
-
Dose-Response Relationship, Drug
-
Drug Administration Schedule
-
Drug Monitoring / psychology
-
Drug Monitoring / standards*
-
Evidence-Based Medicine
-
Female
-
Humans
-
Hypoglycemic Agents / administration & dosage
-
Insulin / administration & dosage*
-
Insulin Infusion Systems / psychology
-
Insulin Infusion Systems / standards*
-
Male
-
Practice Guidelines as Topic*
-
Quality of Life / psychology
-
Treatment Outcome
-
Young Adult
Substances
-
Hypoglycemic Agents
-
Insulin